REF 4100241

Pneumocystis jirovecii Detection & Monitoring Kit

Real-time PCR for qualitative detection of Pneumocystis jirovecii DNA from BAL and sputum samples.

IVD-D CE Qualitative UMS Compatible · Multiplex · 1-mix · 2-channel · 96-well · 24/48/96 reactions

Clinical Use

Qualitative detection of Pneumocystis jirovecii DNA in nucleic acid extracts from BAL and sputum samples. Used as a supportive diagnostic test in immunocompromised patients (HIV, haematological malignancy, solid organ and haematopoietic stem cell transplant recipients, long-term corticosteroid users) with clinical suspicion of Pneumocystis pneumonia (PJP/PCP). Results must be interpreted in conjunction with clinical findings, patient history, imaging and other laboratory results.

This test is designed for qualitative detection. Cq values must not be interpreted as quantitative or semi-quantitative fungal load results.

Test Design

TargetPneumocystis jirovecii (RNL gene)
Internal controlβ-Globin (co-amplification on HEX channel)
Format1-mix mastermix · 2-channel readout (FAM, HEX)
Reaction volume10 µL total (1 µL oligo mix + 5 µL enzyme + 4 µL template)
Cycle time~50 min
Test typeQualitative single-target real-time PCR

Mix → Channel → Target Mapping

MixFAMHEX
Mix 1Pneumocystis jiroveciiInternal Control (β-Globin)

Kit Contents (24-reaction pack)

Oligo Mix1 × 24 µL · primer + probe
Uniqplex Enzyme Mix1 × 120 µL
NTC1 × 1000 µL · negative control
PC (Positive Control)1 × 120 µL · reagent stability control

48- and 96-reaction packs are also available — see IFU §3.

Validated Instruments

  • HiMedia InstaQ96
  • Bio-Rad CFX96 Touch
  • Applied Biosystems QuantStudio 5
  • Qiagen Rotor-Gene Q 5plex

Performance

Typical LoD values for DNA targets are in the range of 50–500 copies/mL in extracted samples; target-specific LoD values are documented in the performance evaluation report. The linear amplification range extends approximately 5–6 log₁₀ above the LoD. Cross-reactivity has been tested against Aspergillus fumigatus/flavus/niger/terreus, Candida albicans/glabrata/krusei, Cryptococcus neoformans, Histoplasma capsulatum, Mycobacterium tuberculosis/avium, Streptococcus pneumoniae, Haemophilus influenzae, Pseudomonas aeruginosa, Klebsiella pneumoniae, Cytomegalovirus, EBV, HSV-1/2 and human saprophytic mycobacterial species; no cross-reactivity was observed.

Storage

Before use (sealed)−20 °C · until expiry date
After opening−20 °C · 4 months (including freeze-thaw)
Freeze-thaw cycleMaximum 3

Regulatory

Class C IVD device. CE marked under the transitional provisions of Regulation (EU) 2017/746. The conformity assessment process under (EU) 2017/746 (IVDR) is ongoing. TİTCK registered. For in vitro diagnostic use only — for laboratory and professional use.